These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 5055013)

  • 21. [Psychiatric complications of L-Dopa treatment of parkinsonism].
    Refsum H
    Tidsskr Nor Laegeforen; 1973 Apr; 93(10):680-5. PubMed ID: 4755082
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical effect of L-DOPA and electromyographic study of Parkinsonism].
    Sato G; Ito H; Handa Y; Takahashi I; Iijima K
    No To Shinkei; 1971 Mar; 23(3):325-32. PubMed ID: 5107821
    [No Abstract]   [Full Text] [Related]  

  • 23. [L-dopa in the treatment of Parkinsonism].
    Domzal T; Pakszys W
    Wiad Lek; 1972 Aug; 25(15):1391-5. PubMed ID: 5073625
    [No Abstract]   [Full Text] [Related]  

  • 24. The metabolism of orally administered L-dopa in Parkinson patients.
    Cote LJ; Cohen G; Yahr MD
    Trans Am Neurol Assoc; 1971; 96():222-3. PubMed ID: 5159086
    [No Abstract]   [Full Text] [Related]  

  • 25. [Trial of L-dopa as hypotensive medication in arterial hypertension. Preliminary report].
    Torres Zamora M; García Monterd G; Chávez Domínguez R; Chávez Lara B; Serrano PA
    Arch Inst Cardiol Mex; 1974; 44(2):267-74. PubMed ID: 4599277
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effects of L-dopa and stereotaxic surgery in Parkinsonism].
    Sugita K; Mutsuga N; Takaoka Y; Takeda A
    No To Shinkei; 1970 Sep; 22(9):1103-8. PubMed ID: 4918927
    [No Abstract]   [Full Text] [Related]  

  • 27. Modification of L-dopa therapy of Parkinsonism by alpha-methyldopa hydrazine (MK-486).
    Yahr MD; Duvoisin RC; Mendoza MR; Schear MJ; Barrett RE
    Trans Am Neurol Assoc; 1971; 96():55-8. PubMed ID: 5159129
    [No Abstract]   [Full Text] [Related]  

  • 28. L-dopa in Parkinson's disease. A report on 95 cases and review of the literature.
    Lewis I
    J Med Assoc State Ala; 1971 May; 40(11):709-18. PubMed ID: 5573008
    [No Abstract]   [Full Text] [Related]  

  • 29. [Abnormal movements induced by L-Dopa and dopamine metabolism disorders].
    Lhermitte F; Rosa A; Comoy E; Bohuon C
    Rev Neurol (Paris); 1973 Dec; 129(6):313-24. PubMed ID: 4794176
    [No Abstract]   [Full Text] [Related]  

  • 30. [L-dopa in the treatment of parkinsonism].
    Goldsztajn M; Reichowa J
    Przegl Lek; 1971 Sep; 27(9):592-3. PubMed ID: 4942580
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of parkinsonism with levo-dopa: results in 302 cases.
    Newkirk TA; Magee KR
    Mich Med; 1971 Sep; 70(22):805-11. PubMed ID: 5141211
    [No Abstract]   [Full Text] [Related]  

  • 32. [Longtime study on the effects of L-dopa therapy in parkinsonism].
    Fischer PA; Schneider E; Jacobi P; Maxion H
    Nervenarzt; 1973 Mar; 44(3):128-35. PubMed ID: 4572536
    [No Abstract]   [Full Text] [Related]  

  • 33. L-dopa treatment of parkinsonism. Clinical observations on the use of amantadine hydrochloride.
    Reveno WS; Bauer RB; Rosenbaum H
    Geriatrics; 1971 Aug; 26(8):61-70. PubMed ID: 5096462
    [No Abstract]   [Full Text] [Related]  

  • 34. L-dopa and Parkinsonism.
    Lond Clin Med J; 1970 Jan; 11(1):5-7. PubMed ID: 5504130
    [No Abstract]   [Full Text] [Related]  

  • 35. L-dopa for Parkinsonism.
    Drug Ther Bull; 1969 Jul; 7(15):59-60. PubMed ID: 5806494
    [No Abstract]   [Full Text] [Related]  

  • 36. [State of catecholamine and DOPA excretion in metabolic-alimentary obesity].
    Frolova IA; Beiul EA; Volkova IS; Sirota II
    Vopr Med Khim; 1974 May; 20(3):257-65. PubMed ID: 4836785
    [No Abstract]   [Full Text] [Related]  

  • 37. [L-DOPA administration in parkinsonism].
    Narabayashi H; Kosaka K
    Naika; 1971; 28(3):436-9. PubMed ID: 5097704
    [No Abstract]   [Full Text] [Related]  

  • 38. [L-DOPA therapy in patients with parkinsonism].
    Stam FC; Heslinga FJ
    Ned Tijdschr Geneeskd; 1970 May; 114(20):849-52. PubMed ID: 5446181
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of Parkinson's syndrome with L-dopa. In operated and nonoperated cases].
    Pimenta Ada M; Friguglietti DJ
    Rev Bras Med; 1971 Sep; 28(9):481-96. PubMed ID: 5139650
    [No Abstract]   [Full Text] [Related]  

  • 40. Excretion of L-dopa and its metabolites in urine of Parkinson's disease patients receiving L-dopa therapy.
    Routh JI; Bannow RE; Fincham RW; Stoll JL
    Clin Chem; 1971 Sep; 17(9):867-71. PubMed ID: 5571485
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.